CN1989412A - 清除粘附性微泡的方法 - Google Patents
清除粘附性微泡的方法 Download PDFInfo
- Publication number
- CN1989412A CN1989412A CNA2005800253451A CN200580025345A CN1989412A CN 1989412 A CN1989412 A CN 1989412A CN A2005800253451 A CNA2005800253451 A CN A2005800253451A CN 200580025345 A CN200580025345 A CN 200580025345A CN 1989412 A CN1989412 A CN 1989412A
- Authority
- CN
- China
- Prior art keywords
- microvesicle
- sample
- antibody
- haematogenous
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000000853 adhesive Substances 0.000 title claims description 18
- 230000001070 adhesive effect Effects 0.000 title claims description 18
- 239000008280 blood Substances 0.000 claims abstract description 28
- 210000004369 blood Anatomy 0.000 claims abstract description 27
- 108010088751 Albumins Proteins 0.000 claims abstract description 24
- 102000009027 Albumins Human genes 0.000 claims abstract description 24
- 238000004458 analytical method Methods 0.000 claims description 9
- 108090000288 Glycoproteins Proteins 0.000 claims description 6
- 102000003886 Glycoproteins Human genes 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 2
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 2
- 230000005875 antibody response Effects 0.000 claims description 2
- 210000001772 blood platelet Anatomy 0.000 description 13
- 238000002965 ELISA Methods 0.000 description 8
- 230000004913 activation Effects 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UYNCFCUHRNOSCN-FYYLOGMGSA-N N-[(1R,2R)-1-hydroxy-3-(4-morpholinyl)-1-phenylpropan-2-yl]decanamide Chemical compound C([C@@H](NC(=O)CCCCCCCCC)[C@H](O)C=1C=CC=CC=1)N1CCOCC1 UYNCFCUHRNOSCN-FYYLOGMGSA-N 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 238000010241 blood sampling Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101001071312 Homo sapiens Platelet glycoprotein IX Proteins 0.000 description 2
- 101001070790 Homo sapiens Platelet glycoprotein Ib alpha chain Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102100036851 Platelet glycoprotein IX Human genes 0.000 description 2
- 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004217387A JP4029298B2 (ja) | 2004-07-26 | 2004-07-26 | 粘着性マイクロベシクルの除去方法 |
JP217387/2004 | 2004-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1989412A true CN1989412A (zh) | 2007-06-27 |
Family
ID=35786114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800253451A Pending CN1989412A (zh) | 2004-07-26 | 2005-07-13 | 清除粘附性微泡的方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080014570A1 (zh) |
EP (1) | EP1780543A4 (zh) |
JP (1) | JP4029298B2 (zh) |
KR (1) | KR100896396B1 (zh) |
CN (1) | CN1989412A (zh) |
AR (1) | AR054974A1 (zh) |
CA (1) | CA2573311A1 (zh) |
TW (1) | TW200606429A (zh) |
WO (1) | WO2006011363A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105393120A (zh) * | 2013-04-09 | 2016-03-09 | Jvc建伍株式会社 | 试样分析用设备及外泌体的捕捉方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3517151B1 (en) * | 2006-03-09 | 2021-04-21 | Aethlon Medical, Inc. | Extracorporeal removal of microvesicular particles |
JPWO2010134567A1 (ja) * | 2009-05-22 | 2012-11-12 | コニカミノルタホールディングス株式会社 | 血中遊離核酸の検出方法 |
JP6210009B2 (ja) * | 2013-09-30 | 2017-10-11 | 株式会社Jvcケンウッド | 試料分析用基板及び基板分析装置 |
JP6201856B2 (ja) * | 2013-11-29 | 2017-09-27 | 株式会社Jvcケンウッド | 分析用基板及び分析用基板の製造方法 |
CN111386122A (zh) * | 2017-09-20 | 2020-07-07 | 分子听诊器公司 | 用于检测组织状况的方法和系统 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE202942T1 (de) * | 1994-04-15 | 2001-07-15 | Cobe Cardiovascular Inc | Blutverträglicher beschichteter artikel |
AR001654A1 (es) * | 1995-04-19 | 1997-11-26 | Univ East Carolina | Método para la descontaminacion microbiana de plaquetas sanguineas |
US6391575B1 (en) * | 1999-03-05 | 2002-05-21 | Idun Pharmaceuticals, Inc. | Methods for detecting membrane derived caspase activity and modulators thereof |
US20020076445A1 (en) * | 2000-02-10 | 2002-06-20 | Crowe John H. | Eukaryotic cells and method for preserving cells |
FR2809181B1 (fr) * | 2000-05-16 | 2002-10-25 | Biocytex | Monoreactif pour le dosage des microparticules plaquettaires |
KR100502275B1 (ko) * | 2002-09-04 | 2005-07-20 | 바디텍메드 주식회사 | 면역분석법을 이용한 혈청 효소의 정량적 측정방법 및 이방법을 이용한 간질환 검사방법 |
US8173595B2 (en) * | 2004-05-04 | 2012-05-08 | The Board Of Trustees Of The University Of Illinois | Methods and compositions for the inhibition of thrombus formation |
-
2004
- 2004-07-26 JP JP2004217387A patent/JP4029298B2/ja not_active Expired - Lifetime
-
2005
- 2005-07-13 CN CNA2005800253451A patent/CN1989412A/zh active Pending
- 2005-07-13 EP EP05765777A patent/EP1780543A4/en not_active Withdrawn
- 2005-07-13 US US11/632,946 patent/US20080014570A1/en not_active Abandoned
- 2005-07-13 KR KR1020077004315A patent/KR100896396B1/ko not_active IP Right Cessation
- 2005-07-13 WO PCT/JP2005/012932 patent/WO2006011363A1/ja active Application Filing
- 2005-07-13 CA CA002573311A patent/CA2573311A1/en not_active Abandoned
- 2005-07-20 TW TW094124488A patent/TW200606429A/zh unknown
- 2005-07-26 AR ARP050103083A patent/AR054974A1/es unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105393120A (zh) * | 2013-04-09 | 2016-03-09 | Jvc建伍株式会社 | 试样分析用设备及外泌体的捕捉方法 |
CN105393120B (zh) * | 2013-04-09 | 2017-07-28 | Jvc建伍株式会社 | 试样分析用设备 |
Also Published As
Publication number | Publication date |
---|---|
KR100896396B1 (ko) | 2009-05-08 |
JP4029298B2 (ja) | 2008-01-09 |
EP1780543A4 (en) | 2007-11-28 |
US20080014570A1 (en) | 2008-01-17 |
JP2006038567A (ja) | 2006-02-09 |
EP1780543A1 (en) | 2007-05-02 |
WO2006011363A1 (ja) | 2006-02-02 |
CA2573311A1 (en) | 2006-02-02 |
AR054974A1 (es) | 2007-08-01 |
TW200606429A (en) | 2006-02-16 |
KR20070051284A (ko) | 2007-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5768371B2 (ja) | 血液試料の複数分析 | |
McIntyre et al. | Antiphospholipid antibodies: discovery, definitions, detection and disease | |
JP3022930B2 (ja) | 移植片受容の改良された評価 | |
CN1989412A (zh) | 清除粘附性微泡的方法 | |
JP3422491B2 (ja) | 方法およびアッセイ | |
CN104215777B (zh) | 一种检测血红蛋白结合磷酸化alpha-突触核蛋白的方法 | |
US6824988B2 (en) | Method and compositions for use in diagnosing and characterizing chronic immune disease | |
CN105223365A (zh) | Gp73胶乳增强免疫比浊法体外定量测定诊断试剂盒 | |
CN104215779B (zh) | 一种检测血红蛋白结合alpha-突触核蛋白的方法 | |
CN101285839B (zh) | 快速检测新城疫病毒的方法及其免疫胶体金测试卡 | |
WO1986005591A1 (fr) | Procede de determination immunologique d'une substance biologique dans un echantillon | |
US6080554A (en) | Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject | |
Fauré et al. | A novel rapid method of red blood cell and platelet permeabilization and staining for flow cytometry analysis | |
JPH05346428A (ja) | 顆粒球の迅速なカウントのためのキット及び前記キットを使用する方法 | |
US20130217050A1 (en) | Method for diagnosing alzheimer's disease using-soluble gpvi | |
JPWO2004018513A1 (ja) | 糖タンパク質若しくは細胞の識別、血清若しくは細胞診断、或いは糖タンパク質若しくは細胞分画のためのレクチンライブラリの使用 | |
WO2005009203A2 (en) | Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis | |
JPWO2004061452A1 (ja) | 抗体の測定方法 | |
JPH07501396A (ja) | Hla(ヒト白血球抗原)のタイプ分け方法 | |
CA2118709A1 (en) | Enzyme capture assay | |
JP2009014572A (ja) | ヒト赤血球が固相化されたクロスマッチ試験用容器の製造方法 | |
EP1840572A1 (en) | A system for the enhancement of the detection of antibodies directed against red cell antigens | |
JPH09145714A (ja) | 血球付着性抗原の測定方法 | |
JPS62503123A (ja) | 免疫複合物の検定のための方法および物品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1101085 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: DA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: DA PHARMACEUTICAL CO., LTD.; APPLICANT Effective date: 20080926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080926 Address of the applicant after: Tokyo, Japan Applicant after: Otsuka Pharmaceutical Co., Ltd. Address of the applicant before: Tokyo Applicant before: Otsuka Pharmaceutical Co., Ltd. Co-applicant before: Gunma Applicant before: KK JIMRO |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20070627 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1101085 Country of ref document: HK |